Personalized medicine for patients with COPD: where are we?

2019 
We would like to apologize to all colleagues whose excellent contributions to the field of personalized COPD medicine could not be included in this text due to space constraints. Part of this work has been funded by German Ministry for Education and Research (BMBF) (ERACoSysMed2 SysMed-COPD-FKZ 031L0140, JPIAMR Pneumo-AMR-Protect-FKZ 01KI1702, e:Med CAPSYS-FKZ 01X1304E/01ZX1304F) to BS and by a Kootstra Talent Fellowship from the Center for Research Innovation, Support and Policy (CRISP) of Maastricht University Medical Center + to BJB. ZonMW (ERACoSysMed 90030355) funded the Dutch consortium partners to FMEF and EFMW. Austrian Science Fund FWF (ERACoSysMed I 3736-B30) funded the Austrian consortium partner SI. NB and FKR were funded by the Norwegian Research Council grant number 284045.
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    195
    References
    31
    Citations
    NaN
    KQI
    []